Soft Tissue Biologics Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Soft Tissue Biologics Market Report Overview

The Soft Tissue Biologics market size was $361.1 Million in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Soft Tissue Biologics are used in surgical procedures to replace, reinforce, or repair tendons or ligaments that have been torn or damaged in the human body. The market focuses on the repair of the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), rotator cuff, and Achilles tendon.

Soft Tissue Biologics Market Outlook, 2023-2033 ($ Million)

Soft Tissue Biologics Market Outlook, 2023-2033 ($ Million)

Buy Full Report for More Insights into The Soft Tissue Biologics Market Forecast

Download a Free Report Sample

The Soft Tissue Biologics market research report explains the market behavior, which will help identify quantitative market trends within the Orthopedic Devices therapeutic area. The model discusses in detail the impact of COVID-19 on the Soft Tissue Biologics market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.

Market Size (2023) $361.1 Million
CAGR (2023-2033) >2%
Forecast Period 2023-2033
Historical Period 2015-2022
Key Regions ·        North America

·        Europe

·        Asia Pacific

·        South America

·        Middle East and Africa

Key Segments ·        Tendon Grafts

·        Tendon Wrapping

Leading Companies ·        Surgalign Holdings Inc

·        ConMed Corp

·        AlloSource

·        Arthrex Inc

·        Smith & Nephew Plc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Soft Tissue Biologics Market Dynamics

The Soft Tissue Biologics market is growing primarily due to the increase in the demand for allografts owing to its convenience, abundance, lack of procurement-related patient morbidity, and availability in various forms. In addition, an increase in the number of sports injuries due to the increased adoption of sports as a profession and growing awareness about physician and patient education in emerging markets will propel the market growth in the future. However, factors such as a lack of knowledge about the working mechanism of soft tissue biologics and insufficient data about clinical efficacy may challenge the market growth.

Soft Tissue Biologics Market Segments

The Soft Tissue Biologics market can be segmented into Tendon Grafts and Tendon Wrapping. In 2023, Tendon Grafts had the largest market share. Tendon grafts or reinforcements provide structural aid to or replacement of the damaged tendon to restore normal function.

Soft Tissue Biologics Market Analysis by Segments, 2023 (%)

Soft Tissue Biologics Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Insights into The Soft Tissue Biologics Market Segments

Download a Free Report Sample

Soft Tissue Biologics Market Segmentation by Regions

The key regions in the Soft Tissue Biologics market are North America, Europe, Asia Pacific, South America, and the Middle East and Africa. North America dominated the market in 2023 with a major contribution from the US market. GlobalData expects an increase in the market size of Soft Tissue Biologics in the forecast period owing to an increasing aging population with orthopedic medical conditions and a growing number of sports injuries.

Soft Tissue Biologics Market Analysis by Regions, 2023 (%)

Soft Tissue Biologics Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Insights into The Soft Tissue Biologics Market Regions

Download a Free Report Sample

Soft Tissue Biologics Market - Competitive Landscape

A few of the leading companies in the Soft Tissue Biologics market are:

  • Surgalign Holdings Inc
  • ConMed Corp
  • AlloSource
  • Arthrex Inc
  • Smith & Nephew Plc

Surgalign Holdings Inc. was leading in the Soft Tissue Biologics market in 2023. It was followed by AlloSource.

Soft Tissue Biologics Market Analysis by Companies, 2023 (%)

Soft Tissue Biologics Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Insights into The Soft Tissue Biologics Market Companies

Download a Free Report Sample

Segments Covered in the Report

Soft Tissue Biologics Segments Outlook (Value, $ Million, 2015-2033)

  • Tendon Grafts
  • Tendon Wrapping

Soft Tissue Biologics Regional Outlook (Value, $ Million, 2015-2033)

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East and Africa

Key Inclusions

Key Inclusions of the market model are:

Currently marketed Soft Tissue Biologics devices and evolving competitive landscape:

– Insightful review of the key industry trends.

– Annualized total Soft Tissue Biologics devices market revenue by segment and market outlooks from 2015-2033.

– Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights:

– Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.

– SWOT analysis for the Soft Tissue Biologics market.

– Competitive dynamics insights and trends provided for the Soft Tissue Biologics market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

– Country-specific overview of the healthcare system.

– Country-specific reimbursement policies.

– Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: LifeNet Health Inc., Sugaralign Holdings Inc., ConMed Corp, Allosource, Arthrex Inc., Smith & Nephew Plc, Stryker Corp, Zimmer Biomet Holdings Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This report provides:

  • Insightful review of the key industry trends.
  • Annualized total Soft Tissue Biologics market revenue by segment and market outlooks.
  • Market-level data on units, average selling prices, and market values.
  • Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for the Soft Tissue Biologics market.
  • Competitive dynamics insights and trends provided for the Soft Tissue Biologics market.
  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Reasons to Buy

The model will enable you to-

  • Understand the impact of COVID-19 on the Soft Tissue Biologics market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Soft Tissue Biologics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies that are likely to impact the Soft Tissue Biologics market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Soft Tissue Biologics market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

LifeNet Health Inc
Sugaralign Holdings Inc
ConMed Corp
Allosource
Arthrex Inc
Smith & Nephew Plc
Stryker Corp
Zimmer Biomet Holdings Inc
Others

Frequently asked questions

Soft Tissue Biologics Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 standard reports
Currency USD
$7,500

Can be used by individual purchaser only

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Soft Tissue Biologics Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Soft Tissue Biologics Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 in real time.

  • Access a live Soft Tissue Biologics Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.